September 2018
Big data and the bog of information
Key questions exist to adopting consumer-grade medical devices, such as how to analyze vast quantities of data in a meaningful way.
Breaking barriers to buprenorphine
Despite heightened awareness of the opioid crisis, treatment still eludes many patients who are struggling with addiction.
Prevention as a prescription for cancer
Lifestyle modification and integrative approaches as interventions for aging well are simple and straightforward, yet these changes can be difficult to implement and sustain.
ACP advocacy for better regulatory policies
Two proposed rules on reducing administrative hassles and improving reimbursement illustrate how ACP influences federal regulatory policies for physicians and patients.
Combat cardiac risks of cancer therapies
One challenge of treating cancer is preventing, diagnosing, and treating heart failure in at-risk patients, and figuring out which patients would benefit from intervention.
Conversing about cancer at ASCO conference
Physician-patient communication has been tied to important outcomes, including quality of life, and a variety of strategies to improve communication exist.
Urban health residencies aim to create primary care leaders
Two residency tracks at Johns Hopkins University in Baltimore focus specifically on urban primary care.
Large valsartan recall, new warnings for fluoroquinolones
This column reviews details on recent recalls, warnings, and approvals.
Candidates for Board of Governors Chair-elect Designee
Two candidates are seeking election as Chair-elect Designee of the Board of Governors, with voting and results announced in late October.
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights of College offerings featured in our e-newsletter, ACP Internist Weekly.
Big data offers information, but as yet few answers
This issue also covers prescribing for opioid addiction, conference coverage from the American Society of Clinical Oncology, and an urban primary care residency at Johns Hopkins University.
MKSAP Quiz: 1-month history of rash
A 52-year-old woman is evaluated for a 1-month history of a spreading rash on her back, chest, and arms. She has been using over-the-counter topical glucocorticoids without relief. She does not have any other associated symptoms and otherwise feels well. Following a physical exam and lab studies, what is the most likely diagnosis?